Abstract
Autoimmune polyendocrine syndrome type 1 (APS1) is an autosomal recessive disorder, which is caused by mutations in a single gene, called autoimmune regulator (AIRE)1,2 .The AIREgene locus is located on the long arm of chromosome 21 and codes for a transcriptional regulator, which is expressed in thymus, lymph nodes, spleen and fetal liver3. The AIREgene locus is believed to be involved in the establishment and maintenance of tolerance3. Absence of a functional AIRE protein results in a complex syndrome with mucocutaneous candidiasis and autoimmune diseases in a single patient12. Most patients with APS 1 are affected by two to six different autoimmune diseases, most of which affect endocrine glands such as parathyroids, adrenals or ovaries4. Ectodermal disease components are found with a high prevalence such as hypoplasia of the dental enamel, nail dystrophy, keratopathy, alopecia and vitiligo4. Less frequent, but severe disease components are disease manifestations which affect the gastrointestinal tract, e.g. malabsorption and hepatitis. Malabsorption may interfere with the treatment of other autoimmune diseases and cause malnutrition in severe cases5. Hepatitis may be mild. However, repeatedly patients were reported who developed lethal fulminant
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc finger domains. Nat Genet. 1970; 17:399–403.
Nagamine K, Peterson P, Scott HS et al. Positional cloning of the APECED gene. Nature Genet. 1997;17:393–398.
Heino M, Peterson P, Kudoh J et al. Autoimmune regulator is expressed in the cells regulating immune tolerance in thymus medulla. Biochem Biophys Res Commun. 1999;257:821–825.
Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyen-docrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.N Engl J Med. 1990;322:1829–1836.
Ekwall O, Hedstrand H, Grimelius L et al. Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet. 1998;352:255–256.
Michele TM, Fleckenstein J, Sgrignoli AR, Tuluvath PJ. Chronic active hepatitis in the type I polyglandular autoimmune syndrome. J Postgrad Med. 1994;70:128–131.
Obermayer-Straub P, Manns MP. The autoimmune polyglandular syndromes. Baillières Clin Gastroenterol. 1999;12:293–315.
Aaltonen J, Börses P, Sandkuijl L, Perheentupa J, and Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nature Genet. 1994;8:83–87.
Seelig HP, Moosbrugger I, Fink T, Renz M, Genth E. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation. Arthritis Rheum. 1995;38:1389–1399.
Ge Q, Nilasena DS, O’Brien CA, Frank MB, Targoff I. Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen. J Clin Invest. 1995;96:1730–1737.
Le Douarin B, Nielsen AL, Gamier JM et al. The N-terminal part of TIF1, a putative mediator of ligand-dependent activation function (AF-2) of nuclear receptors is fused to B-raf in the oncogenic protein T18. EMBO J. 1995;14:2020–2033.
Thenot S, Henriquet C, Rochefort H, Cavailles V. Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIFl. J Biol Chem. 1997;272:12062–12068.
Kim SS, Chen YM, O’Leary E, Witzgall R, Vidal M, Bonventre JV. A novel member of the RING finger family, KRIP-q, associates with the KRAB-A transcriptional repressor domain of zinc finger proteins. Proc Natl Acad Sci USA. 1996; 19:15299–152304.
Blechschmidt K, Schweiger M, Wertz K et al. The mouse Aire gene: comparative genomic sequencing, gene organization, and expression. Genome Res. 1999;9:158–166.
Mittaz L, Rossier C, Heino M et al. Isolation and characterization of the mouse Aire gene. Biochem Biophys Res Commun. 1999;255:483–490.
Wang CY, Shi JD, Davoodi-Semiromi A, She X. Cloning of Aire, the mouse homologue of the autoimmune regulator (AIRE) gene responsible for autoimmune polyglandular syndrome type 1 (APS 1). Genomics. 1999;55:322–326.
Björses P, Aaltonen J, Vikman A et al. Genetic homogeneity of autoimmune polyglandular disease type I.Am J Hum Genet. 1996; 59:879–886.
Rosatelli MC, Meloni A, Meloni A et al. A common mutation in Sardinian autoimmune polyen-docrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet. 1998;103:428–434.
Pearce SHS, Cheetman T, Imrie H et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type 1. Am J Hum Genet. 1998;63:1675–1684.
Wang C-Y, Davoodi-Semiromi A, Connor E, Shi J-D, She J-X. Characterization of mutations in patients with autoimmune polyglandular syndrome type 1 (APSl). Hum Genet. 1998;103:681–685.
Scott HS, Heino M, Peterson P et al. Common mutations in autoimmune polyendocrinopathy-can-didiasis-ectodermal dystrophy patients of different origins. Mol Endocrinol. 1998;12:1112–1119.
Betterle C, Greggio NA, Volpato M. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1998;83:1049–1055.
Neufeld, M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine. 1980;60:355–362.
Li Y, Song YH, Rais N et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest. 1996;97:910–914.
Brown EM, Gamba G, Riccardi D et al. Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid. Nature. 1993; 366:575–580.
Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab. 1987;64:494–500.
Krohn K, Uibo R, Aavik E, Peterson P, Savilahti K. Identification by molecular cloning of an autoantigen associated with Addison’s disease as steroid 17alpha-hydroxylase. Lancet. 1992;339:770–773.
Winqvist O, Karlsson FA, Kämpe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison’s disease. Lancet. 1992;339:1559–1562.
Winqvist O, Gustafsson J, Rorsman F, Karlsson F, Kämpe O. Two different cytochrome P450 enzymes are the adrenal antigens in autoimmune polyendocrine syndrome Type 1 and Addison’s disease. J Clin Invest. 1994;92:2377–2385.
Uibo R, Aavik E, Peterson P, Perheentupa J, Aranko S, Pelkonen R, Krohn KJ. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison’s disease. J Clin Endocrinol Metab. 1994;78:323–328.
Winqvist O, Gebre-Mehedin G, Gustafsson J et al. Identification of the main gonadal autoanti-gens in patients with adrenal insufficiency and associated ovarian failure. J Clin Endocrinol Metab. 1995;80:1717–1723.
Tsatsoulis A, Shalet SM. Antisperm antibodies in the polyglandular autoimmune (PGA) syndrome type I: response to cyclical steroid therapy. Clin Endocrinol Oxf. 1991;35:299–303.
Gorsuch AN, Spencer KM, Lister J et al. Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus. Lancet.1981;2:1363–1365.
Rossini AA, Greiner DL, Friedman HP, Mordes JP. Immunopathogenesis of diabetes mellitus. Diabetes Rev. 1993;1:43–75.
Baekkeskov S, Aanstoot HJ, Christgau S et al. Identification of the 64K autoantigen in insulin-dependent diabetes mellitus as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 1990;347:151–156.
Palmer JP. Insulin autoantibodies: their role in the pathogenesis of IDDM. Diabetes Metab. Rev. 1987;3:1005–1015.
Bruining GJ, Molenaar JL, Grobbee DE et al. Ten-year follow-up study of islet-cell antibodies and childhood diabetes mellitus. Lancet. 1989;1:1100–1103.
Greenbaum CJ, Brooks-Worrell BM, Palmer JP, Lermark A. Autoimmunity and prediction of insulin-dependent diabetes mellitus. In: Marshall H, Home PD, editors. The Diabetes Annual, vol. 8. Amsterdam: Elsevier; 1994: 21–52.
Tuomi T, Bjorses P, Falorni A et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab. 1996;81:1488–1494.
Rorsman F, Husebye ES, Winquist O, BjE, Karlsson FA, Kämpe O. Aromatic L-aminoacid decarboxylase, a pyridoxal phosphate-dependent enzyme, is a beta-cell autoantigen. Proc Natl Acad Sci USA. 1995;92:8626–8629.
Christenson JG, Dairman W, Udenfried S. On the identity of DOPA decarboxylase and 5-hydroxytryptophan decarboxylase (immunological titration-aromatic l-aminoacid decarboxy-lase-serotonin-dopamine-norepinephrine). Proc Natl Acad Sci USA. 1972;69:343–347.
Husebye ES, Gebre-Mehedin G, Tuomi T et al. Autoantibodies against aromatic-L-amino acid decarboxylase in autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab. 1997;82:147–150.
Bereket A, Lowenheim M, Blethen SL, Kane P, Wilson TA. Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. J Clin Endocrinol Metab. 1994;80:933–935.
Ward L, Paquette J, Seidman E et al. Severe autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab. 1999;84:844–851.
McGregor BC, Katz HI, Doe RP. Vitiligo and multiple glandular insufficiencies. J Am Med Assos. 1972;219:724–725.
Bronstoff J. Autoantibodies in patients with vitiligo. Lancet. 1969;2:177–178.
Betterle CA, Pesserico A, Bersani G. Vitiligo and autoimmune polyendocrine deficiencies with autoantibodies to melanin-producing cells. Arch. Dermatol. 1979; 115:364.
Betterle C, Caretto A, Pedini B, Rigon F, Bertoli P, Peserico A. Complement-fixing activity to melanin-producing cells preceding the onset of vitiligo in a patient with type 1 polyglandular failure [letter].Arch Dermatol. 1992;128:123–124.
Hertz KL, Gazze C, Kirkpattrick C, Katz S. Autoimmune vitiligo. N Engl J Med. 1977;297:634–637.
Sacher M, Blümel P, Thaler H, Manns M. Chronic active hepatitis associated with vitiligo, nail dystrophy, alopecia and a new variant of LKM antibodies. J Hepatol. 1990;10:364–369.
Neufeld M, Maclaren N, Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann. 1980;9:154–162.
Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Hormone Metab Res. 1996;28:353–356.
Riley WJ. Autoimmune polyglandular syndromes. Hormone Res. 1992;38(Suppl. 2):9–15.
Clemente MG, Obermayer-Straub P, Meloni A et al. Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab. 1997;82:1353–1361.
Clemente MG, Obermayer-Straub P, Meloni A et al. Cytochrome P450 1A2 as the hepatocellular autoantigen in autoimmune polyendocrine syndrome type 1. J Hepatol. 1995;23(Suppl.l):126.
Manns MP, Griffin KJ, Quattrochi L et al. Identification of cytochrome P450 IA2 as a human autoantigen. Arch Biochem Biophys. 1990;280:229–232.
Bourdi M, Larrey D, Nataf J, Bernuau J et al. Anti-liver endoplasmic reticulum antibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine hepatitis. J Clin Invest. 1990;85:1967–1973.
Homberg JC, Abuaf N, Bernard O et al. Chronic active hepatitis associated with antiliver/kidney microsome type 1: a second type of ‘autoimmune’ hepatitis. Hepatology. 1987;7:1333–1339.
Lindgren S, Braun HB, Michel G et al. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden.Swedish Internal Medicine Liver Club. Scand J Gastroenterol. 1997;32:175–178.
Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology. 1992;103:1290–1295.
Nebert DW, Gonzalez FJ. Cytochrome P450 genes, structure, evolution and regulation. Annu Rev Biochem. 1987;56:945–993.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Obermayer-Straub, P., Manns, M.P. (2000). Hepatitis in the polyendocrine syndrome type 1. In: Manns, M.P., Paumgartner, G., Leuschner, U. (eds) Immunology and Liver. Falk Symposium, vol 114. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-4000-3_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-4000-3_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-5768-4
Online ISBN: 978-94-011-4000-3
eBook Packages: Springer Book Archive